MENU

APRE Aprea Therapeutics Forecast, Technical & Fundamental Analysis

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers... Show more

APRE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
APRE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

APRE is expected to report earnings to fall 7.14% to -6 cents per share on November 05

Aprea Therapeutics APRE Stock Earnings Reports
Q3'26
Est.
$-0.06
Q2'26
Beat
by $0.11
Q1'26
Missed
by $0.10
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.19
The last earnings report on August 12 showed earnings per share of -7 cents, beating the estimate of -18 cents. With 697.43K shares outstanding, the current market capitalization sits at 9.47M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Industry
N/A
Address
3805 Old Easton Road
Phone
+1 215 948-4119
Employees
8
Web
https://www.aprea.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACGL94.261.90
+2.06%
Arch Capital Group Ltd
INTT11.970.14
+1.18%
inTEST Corp
NP27.24-0.11
-0.40%
Neptune Insurance Holdings Inc
NIXX0.31-0.01
-2.45%
Nixxy, Inc.
IVA3.46-0.23
-6.23%
Inventiva SA

APRE and Stocks

Correlation & Price change

A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-3.53%
ATOS - APRE
32%
Poorly correlated
+16.41%
WVE - APRE
28%
Poorly correlated
+4.86%
NTLA - APRE
28%
Poorly correlated
+0.50%
MBRX - APRE
27%
Poorly correlated
+0.68%
STTK - APRE
27%
Poorly correlated
+0.29%
More
Aprea Therapeutics (APRE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com